Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.01M Buy
25,438
+13,232
+108% +$3.74M 0.14% 178
2026
Q1
$3.26M Buy
+12,206
New +$3.38M 0.06% 501
2025
Q4
Sell
-7,738
Closed -$2.23M 1598
2025
Q3
$2.23M Sell
7,738
-962
-11% -$285K 0.05% 554
2025
Q2
$2.88M Buy
+8,700
New +$2.8M 0.07% 440
2025
Q1
Sell
-15,760
Closed -$4.35M 1246
2024
Q4
$4.35M Buy
15,760
+7,046
+81% +$2.25M 0.29% 66
2024
Q3
$3.02M Sell
8,714
-5,559
-39% -$1.91M 0.18% 119
2024
Q2
$4.72M Buy
+14,273
New +$4.92M 0.26% 74
2023
Q2
Sell
-30,314
Closed -$7.75M 1317
2023
Q1
$7.75M Buy
+30,314
New +$8.83M 0.9% 1
2022
Q4
Sell
-6,524
Closed -$1.81M 1036
2022
Q3
$1.81M Buy
+6,524
New +$1.84M 0.18% 161
2022
Q1
Sell
-13,984
Closed -$3.21M 751
2021
Q4
$3.21M Buy
13,984
+3,977
+40% +$845K 0.76% 13
2021
Q3
$2M Buy
10,007
+5,473
+121% +$1.19M 0.36% 60
2021
Q2
$1.07M Buy
4,534
+2,588
+133% +$646K 0.27% 86
2021
Q1
$478K Buy
+1,946
New +$434K 0.13% 267

Other funds holding CI

Y-Intercept (HK)'s CI Position: Q2 2026 in Review

Y-Intercept (HK) increased its Cigna (CI) stake by 108% in Q2 2026, buying an estimated $3.74M and bringing the position to 25,438 shares worth $7.01M. The position accounts for 0.14% of the portfolio, ranked #178.

Y-Intercept (HK) first reported a position in CI in Q1 2021 and has held it in 13 quarters since. The position peaked at $7.75M in Q1 2023. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Y-Intercept (HK) held 25,438 shares of Cigna worth $7.01M as of Q2 2026.
  • Y-Intercept (HK) bought 13,232 Cigna shares in Q2 2026, an estimated $3.74M.
  • Cigna made up 0.14% of Y-Intercept (HK)'s portfolio in Q2 2026, its #178 holding.
  • Y-Intercept (HK) first reported a position in Cigna in Q1 2021 and has held it in 13 quarters since.
  • Y-Intercept (HK)'s Cigna position peaked at $7.75M in Q1 2023.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.